Xenon Pharmaceuticals Inc. (XENE) insider have most recently took part in a trading activity. On Jun 22, 2017 Biotechnology Value Fund L P, 10% Owner bought 20,411 shares having total worth of $81,644 at the price of $4 per share, following the transaction a total of 288,968 shares owned by Biotechnology Value Fund L P. Before this latest buy, Biotechnology Value Fund L P purchased XENE at 2 other times during the past twelve months, for a total investment of $14.68M at an average of $3.83 per share.
The stock has experienced a total of 2 insider trades in the past three months. These trades include 2 buy trades. Furthermore, over the past 12 months , the stock was traded 6 times by insiders. In 3 of these trades, the insider was a seller while an employee of the company was the buyer in 3 instances.
|Time Frame||Number of Insider Buy||Number of Insider Sell||Stock Price Change(%)|
Shares of Xenon Pharmaceuticals Inc. (XENE) traded up 1.25% on Jun 22, 2017, hitting $4.05. 59,250 shares of the company’s stock traded hands. Xenon Pharmaceuticals Inc. has a 52 week low of $3.65 and a 52 week high of $9.85. The company’s market cap is $118 million.
Xenon Pharmaceuticals Inc. (XENE) last announced its earnings results on May 9, 2017. The company reported -0.43 earnings per share (EPS) for the quarter, lower than the consensus estimate of -0.38 by $0.05. The company had revenue of $0 million for the quarter, compared to the consensus estimate of $0 million. During the same quarter in the previous year, the company posted -0.23 earnings per share. The company’s revenue for the quarter was down 97% on a year-over-year basis.
|earnings per share||-0.43||-0.32||-0.51||-0.42||-0.23||-0.27||-0.27||-0.07||-0.30|
Latest posts by William White (see all)
- Insider Trading Review: FS Investment Corporation $FSIC - January 13, 2018
- Insider Trader Watch: ENERTOPIA CORP $ENRT - January 13, 2018
- Insider Trading in Focus: Swiss Helvetia Fund, Inc. (The) $SWZ - January 13, 2018